April 1999
Pages: 572
ISBN 10: 1-56592-444-4 |
ISBN 13: 9781565924444
(Average of 0 Customer Reviews)
This book is OUT OF PRINT.
DescriptionThe sixth most common cancer, non-Hodgkin's lymphomas (NHL) affect 300,000 Americans. In the fast-moving treatment environment, all but super-specialist MDs find it hard to keep abreast of changes that affect the treatments and lives of NHL patients. Non-Hodgkin's Lymphomas helps those living with this disease to participate in wise treatment decisions, as well as to cope with tests, treatment side effects, and other practical issues.
Full Description
In straightforward language and in a format that anticipates the reader's questions, this book addresses diagnosis and its emotional tumult, finding a good oncologist, the theories and practical aspects of treatment, characteristics of non-Hodgkin's lymphomas, side effects and long-term effects of treatment, medical tests and procedures, and prognoses.
Other topics of interest examined are coping with hospitalization, stress and its effects on the immune system, sexuality and fertility after treatment, how to interact successfully with medical personnel, and getting support from family, friends, employers and the broader community. The end of successful treatment and its sometimes surprising effects on one's emotions are covered in a separate chapter, as is the experience of relapse and how to select second-line treatment to regain remission. Clinical trials of promising new therapies grounded in Western medicine are covered in depth. The theories and experiences of marrow transplantation and stem cell support are surveyed. Two frank chapters on recordkeeping, finances, insurance, employment issues, traveling for care, and finding free treatment are included. Throughout the text and in several appendices, the reader is referred to other books, Web sites, and organizations that can provide more detail on a given topic.
This book is intended for both newly diagnosed and long-term survivors of the non-Hodgkin's lymphomas, their caregivers and loved ones, and for medical personnel who interact with survivors of the non-Hodgkin's lymphomas.